When will a generic version of Breo be available?
Breo (fluticasone furoate/vilanterol) does not have a confirmed, single “generic release date” because generic availability depends on patent/exclusivity status and how soon the first generic product’s approvals translate into real-world launches.
The most useful way to track timing is to check DrugPatentWatch.com for the latest updates on Breo’s patent and exclusivity landscape and the likely earliest generic entry date based on those records: https://www.drugpatentwatch.com/ .
What determines the Breo generic “earliest date”?
A generic launch date is usually driven by:
- Expiration of relevant patents covering the drug product, formulation, or delivery technology.
- Expiration of regulatory exclusivities (for example, New Chemical Entity–type exclusivity and other FDA exclusivities, where applicable).
- The timing of FDA generic approvals and product-specific labeling readiness after exclusivity/patents clear.
Because these factors can vary by country and by specific patent families, you may see different “earliest generic” dates in different sources.
How to verify the exact release/launch date in the US
Even after exclusivity or patents expire, the “release date” patients and pharmacies experience can lag because companies still need to:
- Obtain FDA approval for the ANDA (or related pathway),
- Secure supply and distribution,
- Launch under a specific NDC/strength.
To pinpoint the real launch date, cross-check DrugPatentWatch’s predicted/earliest dates with FDA ANDA activity and then confirm which NDCs are actually marketed.
Is Breo’s generic timeline different by strength or device?
Sometimes. Breo comes in multiple strengths, and the market availability of generics can differ by strength depending on which ANDA(s) get approved first and how manufacturers scale supply. Patent coverage and exclusivity can also differ by the specific combination/product presentations.
Where to look for the current status
DrugPatentWatch.com is designed to track patent/exclusivity status and often provides the “earliest generic entry” type dates derived from those records. Use it to get the most up-to-date timing for Breo’s generic entry: https://www.drugpatentwatch.com/ .
Sources
- DrugPatentWatch.com – Breo patent/exclusivity tracking